Kinase, in vitro: 

An enzyme-substrate reaction that occurs in non-living experimental conditions such as a test tube. For example, a purified enzyme is reacted with a substrate protein or mixture of proteins or peptides.

Akt1 S143-p
CDK5 S154-p
GSK3B S714-p
mTOR S714-p
 Putative in vivo kinases: 

An enzyme-substrate reaction that occurs within living cells; includes cultured cells, ex vivo samples, and intact organisms. In the case of kinases, the large number of protein kinases in intact cells makes exact identification of the responsible kinase challenging.

Akt1 S143-p
CDK1 S154-p
CDK2 S154-p
CDK4 S127-p , S954-p
CDK5 S154-p
GSK3B S714-p
Regulatory protein:
HDAC2 K160-ac , K188-ac , K259-ac , K366-ac , K749-ac , K891-ac , K957-ac , K961-ac , K975-ac , K1054-ac , K1111-ac , K1113-ac , K1115-ac , K1117-ac , K1349-ac , K1415-ac
PRP4 S141-p , S714-p
SET S714-p
SIRT6 K160-ac , K188-ac , K259-ac , K366-ac , K749-ac , K891-ac , K957-ac , K961-ac , K975-ac , K1054-ac , K1111-ac , K1113-ac , K1115-ac , K1117-ac , K1349-ac , K1415-ac
SIRT7 K160-ac , K188-ac , K259-ac , K366-ac , K749-ac , K891-ac , K957-ac , K961-ac , K975-ac , K1054-ac , K1111-ac , K1113-ac , K1115-ac , K1117-ac , K1349-ac , K1415-ac
Treatment:
6-Thioguanine K142-m1
angiotensin_2 S143-p , S154-p
BI2536 S394-p
BI_4834 S732-p
calyculin_A S143-p
CBB1003 K142-m1
CHIR99021 S714-p
cisplatin S714-p
CXCL12 T168-p
dasatinib S714-p
EGF S127-p , S714-p , S732-p , S1105-p
GSK3i 71 S714-p
IGF-1 S714-p
insulin S143-p
ischemia S127-p
LDL_oxidized S154-p
LY294002 S143-p
metformin S143-p
MG132 K928-ub , K1572-ub
MLN8054 S394-p
MS275 K173-ac
NAC S154-p
nicotinamide K160-ac , K188-ac , K259-ac , K366-ac , K749-ac , K891-ac , K957-ac , K961-ac , K975-ac , K1054-ac , K1111-ac , K1113-ac , K1115-ac , K1117-ac , K1349-ac , K1415-ac
nocodazole T208-p , S209-p , S394-p
peptide_agonist S143-p
RO-3306 S714-p
selisistat K160-ac , K188-ac , K259-ac , K366-ac , K749-ac , K891-ac , K957-ac , K961-ac , K975-ac , K1054-ac , K1111-ac , K1113-ac , K1115-ac , K1117-ac , K1349-ac , K1415-ac
selumetinib S141-p
serum S714-p
siRNA K142-m1 , S143-p , K160-ac , K188-ac , K259-ac , K366-ac , S714-p , K749-ac , K891-ac , K957-ac , K961-ac , K975-ac , K1054-ac , K1111-ac , K1113-ac , K1115-ac , K1117-ac , K1349-ac , K1415-ac
sodium_phosphate S154-p
splitomicin K160-ac , K188-ac , K259-ac , K366-ac , K749-ac , K891-ac , K957-ac , K961-ac , K975-ac , K1054-ac , K1111-ac , K1113-ac , K1115-ac , K1117-ac , K1349-ac , K1415-ac
Torin1 S714-p
trichostatin_A K160-ac , K188-ac , K259-ac , K366-ac , K749-ac , K891-ac , K957-ac , K961-ac , K975-ac , K1054-ac , K1111-ac , K1113-ac , K1115-ac , K1117-ac , K1349-ac , K1415-ac
vemurafenib S141-p